Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S E Ward
Reply: The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine
Clinical Colorectal Cancer
Oncology
Gastroenterology
Role of Capecitabine in Treating Metastatic Colorectal Cancer in Chinese Patients
OncoTargets and Therapy
Oncology
Pharmacology
Phase I Clinical Trial of a Peptide Vaccine Combined With Tegafur-Uracil Plus Leucovorin for Treatment of Advanced or Recurrent Colorectal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma
Association Between SLCO1B1 Rs4149056 and Tegafur–uracil-Induced Hepatic Dysfunction in Breast Cancer
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study
Oncologist
Cancer Research
Medicine
Oncology
